risperidone has been researched along with mianserin in 38 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (10.53) | 18.2507 |
| 2000's | 14 (36.84) | 29.6817 |
| 2010's | 20 (52.63) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Druck, T; Hamblin, MW; Huebner, K; Khan, N; Kohen, R; Lachowicz, JE; Meltzer, HY; Metcalf, MA; Roth, BL; Sibley, DR | 1 |
| Egan, CT; Herrick-Davis, K; Teitler, M | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Itoh, H; Muramatsu, I; Taniguchi, T; Yoshio, R | 1 |
| Glennon, RA | 1 |
| Alonso, JM; Andrés, JI; Cid, JM; Díaz, A; Fernández, J; Gil, P; Iturrino, L; Megens, A; Sipido, VK; Trabanco, AA | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Cleves, AE; Jain, AN; Kirshner, D; Langham, JJ; Spitzer, R | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Caradonna, NP; Hallifax, D; Houston, JB; Turlizzi, E; Zanelli, U | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Alsayegh, L; Backstrom, JR; Berry, SA; Friedman, L; Roth, BL; Sanders-Bush, E; Willins, DL | 1 |
| Doorschot, CH; Loonen, AJ; Oostelbos, MC; Sitsen, JM | 1 |
| Blass, DM; Pearson, VE | 1 |
| Huang, XF; Zavitsanou, K | 1 |
| Danileviciūte, V | 1 |
| Canale, A; Crucitti, D; D'Arrigo, C; Malara, G; Muscatello, MR; Spina, E; Torre, DL; Zoccali, R | 1 |
| Drobizhev, MIu; Kozyrev, VN; Kraeva, GK; Kubrakov, MA; Smulevich, AB | 1 |
| Chandra, PS; Chaturvedi, SK; Gupta, A; Prabhu, SC; Ranjan, S | 1 |
| Argiriou, S; Knopf, U; Kuwilsky, A; Zink, M | 1 |
| Harada, D; Hayashida, K; Ishino, H; Ito, H; Nakayama, K | 1 |
| Abbasi, SH; Akhondzadeh, S; Behpournia, H; Ghoreshi, A; Raznahan, M; Rezaei, F; Rezazadeh, SA; Salehi, B | 1 |
| Cho, SJ; Choi, TK; Kim, B; Kim, YW; Lee, JE; Lee, KS; Lee, SH; Suh, S; Yook, K; Yook, KH | 1 |
| Lai, CH | 1 |
| Gądek-Michalska, A; Kabziński, M; Rachwalska, P; Rogóż, Z; Sadaj, W | 1 |
| Rogóż, Z | 2 |
| Gołembiowska, K; Kamińska, K; Rogóż, Z | 1 |
| Kamińska, K; Rogóż, Z | 1 |
| Khouzam, HR | 1 |
| Bonse, A; Hempel, G; Lingg, R; Oberfeld, S; Telger, K; Weber, J | 1 |
| Hastings, M; May, T; Urbina, TM | 1 |
| Kamińska, K; Pańczyszyn-Trzewik, P; Rogóż, Z; Sowa-Kućma, M | 1 |
| Akagawa, Y; Ikeda, J; Ishii, W; Sekijima, Y; Shishido-Hara, Y; Ueno, A | 1 |
| Górska, A; Gołembiowska, K; Kamińska, K; Noworyta-Sokołowska, K; Rogóż, Z; Wojtas, A | 1 |
| Hiwatani, Y; Nakane, S; Nakayama, Y; Takahashi, S; Tsuji, T; Uenishi, S; Ukai, S | 1 |
3 review(s) available for risperidone and mianserin
| Article | Year |
|---|---|
Higher-end serotonin receptors: 5-HT(5), 5-HT(6), and 5-HT(7).
Topics: Animals; Humans; Ligands; Receptors, Serotonin; Serotonin Agents; Serotonin Antagonists; Serotonin Receptor Agonists | 2003 |
[Schizoaffective disorder: clinical symptoms and present-day approach to treatment].
Topics: Adolescent; Amisulpride; Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Carbamazepine; Child; Diagnosis, Differential; Dibenzothiazepines; Dogs; Female; Humans; Imidazoles; Indoles; Lithium Carbonate; Male; Mianserin; Middle Aged; Mirtazapine; Olanzapine; Piperazines; Pirenzepine; Placebos; Prognosis; Psychotic Disorders; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Sulpiride; Thiazoles; Time Factors | 2002 |
Psychopharmacology of chronic pain: a focus on antidepressants and atypical antipsychotics.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bupropion; Chronic Pain; Humans; Mianserin; Mirtazapine; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Thiazoles; Trazodone; Triazoles | 2016 |
3 trial(s) available for risperidone and mianserin
| Article | Year |
|---|---|
Lack of drug interactions between mirtazapine and risperidone in psychiatric patients: a pilot study.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Depression; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Female; Humans; Isoxazoles; Male; Mianserin; Middle Aged; Mirtazapine; Paliperidone Palmitate; Pilot Projects; Psychotic Disorders; Pyrimidines; Risperidone; Severity of Illness Index; Treatment Outcome | 1999 |
The effect of mirtazapine add on therapy to risperidone in the treatment of schizophrenia: a double-blind randomized placebo-controlled trial.
Topics: Adult; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Double-Blind Method; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Prospective Studies; Psychiatric Status Rating Scales; Regression Analysis; Risperidone; Schizophrenia; Treatment Outcome; Young Adult | 2010 |
Mirtazapine augmentation enhances cognitive and reduces negative symptoms in schizophrenia patients treated with risperidone: a randomized controlled trial.
Topics: Adult; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Cognition Disorders; Double-Blind Method; Drug Synergism; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Psychiatric Status Rating Scales; Retrospective Studies; Risperidone; Schizophrenia | 2011 |
32 other study(ies) available for risperidone and mianserin
| Article | Year |
|---|---|
Cloning, characterization, and chromosomal localization of a human 5-HT6 serotonin receptor.
Topics: Adenylyl Cyclases; Amino Acid Sequence; Animals; Antipsychotic Agents; Base Sequence; Brain Chemistry; Cell Line, Transformed; Chlorocebus aethiops; Chromosome Mapping; Chromosomes, Human, Pair 1; Cloning, Molecular; Clozapine; DNA, Complementary; Genes; Humans; Kinetics; Molecular Sequence Data; Open Reading Frames; Protein Conformation; Rats; Receptors, Serotonin; Recombinant Proteins; Sequence Alignment; Sequence Homology, Nucleic Acid; Serotonin Agents; Signal Transduction; Species Specificity | 1996 |
Creation of a constitutively activated state of the 5-hydroxytryptamine2A receptor by site-directed mutagenesis: inverse agonist activity of antipsychotic drugs.
Topics: Animals; Antipsychotic Agents; COS Cells; Mutagenesis, Site-Directed; Phosphatidylinositols; Protein Conformation; Rats; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Serotonin; Serotonin Receptor Agonists; Structure-Activity Relationship | 1998 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Affinity of serotonin receptor antagonists and agonists to recombinant and native alpha1-adrenoceptor subtypes.
Topics: Animals; Aorta, Thoracic; Carotid Arteries; Dogs; Humans; Male; Organ Culture Techniques; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Recombinant Proteins; Serotonin Antagonists; Serotonin Receptor Agonists | 2001 |
Discovery of new tetracyclic tetrahydrofuran derivatives as potential broad-spectrum psychotropic agents.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Furans; Heterocyclic Compounds, 4 or More Rings; Humans; In Vitro Techniques; Mice; Psychotropic Drugs; Radioligand Assay; Rats; Stereoisomerism; Structure-Activity Relationship | 2005 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physical binding pocket induction for affinity prediction.
Topics: Binding Sites; Ligands; Models, Molecular; Neural Networks, Computer; Peptide Fragments; Protein Binding; Receptor, Serotonin, 5-HT1A | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Comparison of cryopreserved HepaRG cells with cryopreserved human hepatocytes for prediction of clearance for 26 drugs.
Topics: Cell Line, Tumor; Cryopreservation; Female; Hepatocytes; Humans; Male; Metabolic Clearance Rate; Pharmaceutical Preparations; Predictive Value of Tests | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Clozapine and other 5-hydroxytryptamine-2A receptor antagonists alter the subcellular distribution of 5-hydroxytryptamine-2A receptors in vitro and in vivo.
Topics: 3T3 Cells; Animals; Antipsychotic Agents; Benzodiazepines; Cell Line; Clozapine; Dendrites; Fluorobenzenes; Haloperidol; Mianserin; Mice; Olanzapine; Piperidines; Pirenzepine; Prefrontal Cortex; Pyramidal Cells; Rats; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Recombinant Proteins; Risperidone; Ritanserin; Serotonin Antagonists; Transfection | 1999 |
SIADH with multiple antidepressants in a geriatric patient.
Topics: Aged; Antidepressive Agents; Antipsychotic Agents; Bupropion; Cyclohexanols; Depressive Disorder; Humans; Inappropriate ADH Syndrome; Mianserin; Mirtazapine; Risperidone; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2000 |
Decreased [(3)H]spiperone binding in the anterior cingulate cortex of schizophrenia patients: an autoradiographic study.
Topics: Adult; Aged; Antipsychotic Agents; Binding Sites; Binding, Competitive; Butaclamol; Down-Regulation; Gyrus Cinguli; Haloperidol; Humans; Mianserin; Middle Aged; Neurons; Neurotransmitter Agents; Radioligand Assay; Receptors, Neurotransmitter; Risperidone; Schizophrenia; Spiperone; Tritium | 2002 |
Lack of a pharmacokinetic interaction between mirtazapine and the newer antipsychotics clozapine, risperidone and olanzapine in patients with chronic schizophrenia.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Clinical Trials as Topic; Clozapine; Drug Administration Schedule; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Italy; Male; Mianserin; Middle Aged; Mirtazapine; Olanzapine; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Time Factors | 2003 |
[Psychotropic drugs used in a psychiatric hospital (pharmaco-epidemiologic aspects)].
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Carbazoles; Chlorprothixene; Clopenthixol; Data Collection; Dopamine Antagonists; Female; Fluoxetine; Flupenthixol; Hospitals, Psychiatric; Humans; Male; Mental Disorders; Mianserin; Middle Aged; Mirtazapine; Monoamine Oxidase Inhibitors; Moscow; Nootropic Agents; Olanzapine; Pharmacoepidemiology; Phenothiazines; Psychotropic Drugs; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sulpiride | 2003 |
Atypical antipsychotic-induced akathisia with depression: therapeutic role of mirtazapine.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Benzodiazepines; Female; Humans; Male; Mianserin; Mirtazapine; Olanzapine; Risperidone; Serotonin Antagonists; Treatment Outcome | 2006 |
A case of pulmonary thromboembolism and rhabdomyolysis during therapy with mirtazapine and risperidone.
Topics: Adult; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Comorbidity; Depressive Disorder, Major; Drug Therapy, Combination; Humans; Male; Mianserin; Mirtazapine; Pulmonary Embolism; Rhabdomyolysis; Risperidone; Schizophrenia | 2006 |
[Psychiatry and sleep disorders--delirium].
Topics: Age Factors; Aged; Aged, 80 and over; Antipsychotic Agents; Delirium; Female; Haloperidol; Humans; International Classification of Diseases; Japan; Male; Mianserin; Middle Aged; Neoplasms; Risperidone; Sex Factors; Tiapamil Hydrochloride; Treatment Outcome | 2006 |
Dissociative identity disorder may be relieved by the combined treatments of mirtazapine and risperidone: case report of an adolescent.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Dissociative Identity Disorder; Drug Therapy, Combination; Female; Humans; Mianserin; Mirtazapine; Risperidone | 2012 |
Effect of co-treatment with fluoxetine or mirtazapine and risperidone on the active behaviors and plasma corticosterone concentration in rats subjected to the forced swim test.
Topics: Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Behavior, Animal; Corticosterone; Depression; Disease Models, Animal; Drug Interactions; Drug Therapy, Combination; Exploratory Behavior; Fluoxetine; Male; Mianserin; Mirtazapine; Motor Activity; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT1 Receptor Antagonists; Swimming | 2012 |
Effect of co-treatment with mirtazapine and risperidone in animal models of the positive symptoms of schizophrenia in mice.
Topics: Amphetamines; Animals; Antipsychotic Agents; Behavior, Animal; Dextroamphetamine; Disease Models, Animal; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hyperkinesis; Male; Mianserin; Mice; Mirtazapine; Motor Activity; Risperidone; Schizophrenia; Schizophrenic Psychology | 2012 |
Effect of combined treatment with mirtazapine and risperidone on the MK-801-induced changes in the object recognition test in mice.
Topics: Animals; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Behavior, Animal; Brain; Cognition; Dizocilpine Maleate; Drug Interactions; Excitatory Amino Acid Antagonists; Male; Mianserin; Mice; Mirtazapine; Motor Activity; Receptors, N-Methyl-D-Aspartate; Recognition, Psychology; Risperidone | 2013 |
The effect of risperidone on the mirtazapine-induced changes in extracellular monoamines in the rat frontal cortex.
Topics: Animals; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Chromatography, High Pressure Liquid; Dopamine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Frontal Lobe; Injections, Intraperitoneal; Mianserin; Microdialysis; Mirtazapine; Norepinephrine; Piperazines; Pyridines; Rats; Risperidone; Serotonin | 2014 |
The effect of combined treatment with risperidone and antidepressants on the MK-801-induced deficits in the social interaction test in rats.
Topics: Animals; Antidepressive Agents; Citalopram; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Synergism; Male; Mianserin; Mirtazapine; Rats; Risperidone; Social Behavior | 2015 |
Validation of a dried blood spot method for therapeutic drug monitoring of citalopram, mirtazapine and risperidone and its active metabolite 9-hydroxyrisperidone using HPLC-MS.
Topics: Chromatography, High Pressure Liquid; Chromatography, Liquid; Citalopram; Dried Blood Spot Testing; Drug Monitoring; Humans; Mianserin; Mirtazapine; Paliperidone Palmitate; Reproducibility of Results; Risperidone; Tandem Mass Spectrometry | 2017 |
Navigating Undiagnosed Dissociative Identity Disorder in the Inpatient Setting: A Case Report.
Topics: Adaptation, Psychological; Adult; Antidepressive Agents; Antipsychotic Agents; Cognitive Behavioral Therapy; Dissociative Identity Disorder; Female; Hospitalization; Humans; Inpatients; Mianserin; Mirtazapine; Risperidone; Sertraline; Treatment Outcome | 2017 |
Repeated co-treatment with antidepressants and risperidone increases BDNF mRNA and protein levels in rats.
Topics: Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Citalopram; Drug Interactions; Fluoxetine; Frontal Lobe; Gene Expression Regulation; Hippocampus; Mianserin; Mirtazapine; Rats; Rats, Wistar; Risperidone; RNA, Messenger; Serotonin Antagonists | 2017 |
[Two patients with progressive multifocal leukoencephalopathy with immune response against JC virus showing good long-term outcome by combination therapy of mefloquine, mirtazapine, and risperidone].
Topics: Adult; Brain; Drug Therapy, Combination; Female; Humans; Immunity, Cellular; JC Virus; Leukoencephalopathy, Progressive Multifocal; Magnetic Resonance Imaging; Mefloquine; Mianserin; Middle Aged; Mirtazapine; Risperidone; Time Factors; Treatment Outcome | 2018 |
The effect of chronic co-treatment with risperidone and novel antidepressant drugs on the dopamine and serotonin levels in the rats frontal cortex.
Topics: Animals; Antidepressive Agents; Catalepsy; Citalopram; Dopamine; Drug Synergism; Frontal Lobe; Locomotion; Male; Mianserin; Mirtazapine; Rats; Recognition, Psychology; Risperidone; Serotonin | 2018 |
A case of autoimmune autonomic ganglionopathy with prolonged delirium.
Topics: Adrenergic alpha-Antagonists; Aged; Antipsychotic Agents; Autoimmune Diseases; Autonomic Nervous System Diseases; Brain; Delirium; Diagnosis, Differential; Electroencephalography; Humans; Immunoglobulins; Indenes; Magnetic Resonance Imaging; Male; Mianserin; Risperidone; Time; Tomography, X-Ray Computed | 2019 |